[Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
R Sánchez SánchezA Rodríguez FernándezM Gómez RíoA Alkurdi MartínezV E Castellón RubioC Ramos FontA Sánchez-Palencia RamosJ R Delgado PérezJ M Llamas ElviraPublished in: Revista espanola de medicina nuclear (2011)
Our data show that integrated PET/CT provides high sensitivity and positive predictive value in mediastinal nodal staging of NSCLC patients. Therefore, in patients with potentially resectable lung cancer, neoadjuvant chemotherapy candidate, mediastinoscopy could be reserved for restaging after induction therapy.
Keyphrases
- pet ct
- neoadjuvant chemotherapy
- lymph node
- locally advanced
- positron emission tomography
- end stage renal disease
- sentinel lymph node
- chronic kidney disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- prognostic factors
- ultrasound guided
- squamous cell carcinoma
- computed tomography
- stem cells
- machine learning
- big data
- advanced non small cell lung cancer
- patient reported outcomes
- bone marrow
- artificial intelligence
- deep learning